Treatment for hepatocellular carcinoma in Japan over the last three decades: Our experience and published work review

@inproceedings{Osaki2015TreatmentFH,
  title={Treatment for hepatocellular carcinoma in Japan over the last three decades: Our experience and published work review},
  author={Yukio Osaki and Hiroki Nishikawa},
  booktitle={Hepatology research : the official journal of the Japan Society of Hepatology},
  year={2015}
}
Hepatocellular carcinoma (HCC) is one of the most common causes of cancer-related mortality worldwide. In the last few decades, there has been a marked increase in therapeutic options for HCC and epidemiological characteristics at HCC diagnosis have also significantly changed. With these changes and advances in medical technology and surveillance program for detecting earlier stage HCC, survival in patients with HCC has significantly improved. Especially, patients with liver cirrhosis are at… CONTINUE READING